MAGNA LAB INC
SC 13D, 1998-01-16
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: MAGNA LAB INC, 10QSB, 1998-01-16
Next: GENERAL GROWTH PROPERTIES INC, 10-Q/A, 1998-01-16



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D



                    Under the Securities Exchange Act of 1934


                                 Magna-Lab, Inc.
                                (Name of Issuer)



                     Common Stock, Par Value $.001 Per Share
                          Title of Class of Securities)



                                   559235 10 6
                                 (CUSIP Number)

          Lawrence A. Mankoff, P.O. Box 1313, Brentwood, NY 11717-0689
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                                  January 1998
             (Date of Event which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box O.






<PAGE>
                                  SCHEDULE 13D


CUSIP No.559235 10 6                         Page      2   of     5     Page
                                                  --------    ---------





                1     NAME OF REPORTING PERSON
                      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                      Robert M. Rubin

                2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) [  ]
                                                                        (b) [  ]

                3     SEC USE ONLY

        
                4     SOURCE OF FUNDS
                      PF

                5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 
                      PURSUANT TO ITEMS 2(D) OR 2(E)   [  ]

                6     CITIZENSHIP OR PLACE OF ORGANIZATION

                      United States



Number 
of Shares      7      SOLE VOTING POWER
Owned                 2,400,000
By Each 
Reporting      8      SHARED VOTING POWER
Person                0
With           
               9      SOLE DISPOSITIVE POWER
                      2,400,000

               10     SHARED DISPOSITIVE POWER
                      0

               11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING 
                      PERSON

                      2,400,000

               12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) 
                      EXCLUDES CERTAIN SHARES     [ ]


<PAGE>
CUSIP No.559235 10 6                         Page      3   of    5      Page
                                                  --------    ---------

 


               13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                      12.70%

               14     TYPE OF REPORTING PERSON

                      IN

Item 1.           Security and Issuer.

     This  statement  on Schedule  13D (the  "Statement")  relates to the common
stock,  par value $0.001 per share (the "Common Stock"),  of Magna-Lab,  Inc., a
New York corporation (the "Company"),  with its principal  executive  offices in
Brentwood, New York (P.O. Box 1313, 11717-0689).

Item 2.           Identity and Background.

     (a) - (f). This  Statement is being filed by Robert M. Rubin.  Mr.  Rubin's
principal  business  address is c/o American United Global,  Inc. 1130 Northeast
33rd Place,  Suite 250,  Bellview,  Washington  98004.  Mr. Rubin is primarily a
venture capitalist. Mr. Rubin is a United States citizen.

     During  the last five  years  Mr.  Rubin  has not (i) been  convicted  in a
criminal  proceeding or (ii) been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is  subject  to a  judgment,  decree  or  final  order  enjoining  future
violations  of, or prohibiting  or mandating  activities  subject to, Federal or
state securities laws or finding any violation with respect to such laws.



<PAGE>
CUSIP No.559235 10 6                         Page      4   of     5     Page
                                                  --------    ---------



Item 3.           Source and Amount of Funds or Other Consideration.

     The aggregate  purchase  price of $300,000 came from Mr.  Rubin's  personal
funds.

Item 4.           Purpose of Transaction.

     The Shares were acquired in a private placement for investment purposes.

Item 5.           Interest in Securities of the Issuer.

     (a) Mr. Rubin  beneficially  owns, in the  aggregate,  2,400,000  shares of
Common Stock or 12.70% of the outstanding shares of Common Stock as of the date.

     (b)  Mr.  Rubin  possesses  the  sole  power  to  dispose  of,  direct  the
disposition of and vote all 2,400,00 shares

     (c)  Within  the past 60 days  from the date  hereof,  Mr.  Rubin  acquired
2,400,000  shares in a private  placement at a purchase price of $.125 per share
for an aggregate purchase price of $300,000.

Item 6.           Contracts, Arrangements, Understandings or Relationships with 
                  Respect to Securities of the Issuer.

     There  are no  contracts,  arrangements,  understandings  or  relationships
(legal or otherwise)  between Mr. Rubin and any other person with respect to any
securities of the Company.



<PAGE>
CUSIP No.559235 10 6                         Page      5   of     5     Page
                                                  --------    ---------


Item 7.           Material to be Filed as Exhibits.

     There are no exhibits required to be filed.

                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.



Date: January 15, 1998



                                                             /s/ Robert M. Rubin
                                                             -------------------
                                                                 Robert M. Rubin



<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission